Table 2.
Country | Number | Presence of genes and mutations conferring antimicrobial resistance (%) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GEN | ERY | OXA | FUS | TET | CIP | RIF | TMP | QAC | FOF | ||
Belgium | 2 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 100 | 100 | 0 |
Germany | 10 | 90 | 90 | 90 | 40 | 10 | 90 | 20 | 40 | 90 | 50 |
Japan | 14 | 64 | 64 | 100 | 0 | 43 | 57 | 0 | 0 | 21 | 46 |
Norway | 54 | 83 | 74 | 83 | 35 | 30 | 41 | 0 | 11 | 69 | 7 |
Spain | 2 | 100 | 50 | 100 | 50 | 50 | 100 | 0 | 100 | 50 | 0 |
Switzerland | 43 | 79 | 90 | 70 | 42 | 28 | 63 | 2 | 12 | 79 | 33 |
UK | 9 | 78 | 78 | 78 | 44 | 67 | 67 | 22 | 56 | 78 | 22 |
USA | 1 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GEN, gentamicin; ERY, erythromycin; OXA, oxacillin; FUS, fusidic acid; TET, tetracycline; CIP, ciprofloxacin; RIF, rifampicin; TMP, trimethoprim; QAC, quaternary ammonium compounds; FOF, fosfomycin.